Effects of Robuvit® on the progression of non-alcoholic fatty liver disease.
Belcaro G, Cox DM, Cesarone MR, Gizzi G, Pellegrini L, Scipione C, Scipione V, Dugall M, Hu S, Corsi M, Feragalli B, Cotellese R.
Belcaro G, et al. Among authors: gizzi g.
Minerva Gastroenterol (Torino). 2022 Dec;68(4):434-441. doi: 10.23736/S2724-5985.22.03201-6.
Minerva Gastroenterol (Torino). 2022.
PMID: 36507829